Back to FEDERATED HERMES, INC. FEDERATED HERMES, INC.

KALVKALV
11 quarters

Position history for FEDERATED HERMES, INC.FEDERATED HERMES, INC.'s holdings in KALVISTA PHARMACEUTICALS INC

As of its Q1 2026 13F, Federated Hermes held 3,719 shares of KALV (Kalvista Pharmaceuticals), worth $74,864. Federated Hermes' 13F filings listed KALV from Q4 2025 to Q1 2026, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$6,000

Total Shares Change

-286

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$27.00
0
2026-Q1
Increased
3,719
+4858.7%
$74,8640.0%$15.61
34
2025-Q4
New
75
-
$1,2110.0%$15.68
17
2021-Q3
Exited
0
-100.0%
$00.0%$17.11
0
2021-Q2
Unchanged
39
0.0%
$1,0000.0%$23.99
0
2021-Q1
New
39
-
$1,0000.0%$25.70
17
2020-Q2
Exited
0
-100.0%
$00.0%$12.66
0
2020-Q1
New
266
-
$2,0000.0%$7.55
17
2019-Q2
Exited
0
-100.0%
$00.0%$22.15
0
2019-Q1
Increased
491
+71.7%
$14,0000.0%$28.62
18
2018-Q4
First report
286
-
$6,0000.0%$19.56
0

Other major holders of KALV: BlackRock, Inc., Capital World Investors, MILLENNIUM MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used